| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.025 | 0.8 |